Patent Assignment
Reel/Frame 043045/0913
Security Interest
Recorded: 2017-07-19
Pages: 10
Assignor
VALEANT PHARMACEUTICALS INTERNATIONAL
Executed: 2017-07-17
Assignee
THE BANK OF NEW YORK MELLON
101 BARCLAY STREET, FLOOR 7E, NEW YORK, NEW YORK, 10286
Covered Properties
(20)
Purification and Characterization of Cytotoxic Lymphocyte Maturation Factor and Monoclonal Antibodies Thereto
Patent:
6,683,046 →
Application:
08/459,151 →
Novel Modifications of 2-Amino-4-(4-Fluorobenzylamino)- 1-Ethoxycarbonylaminobenzene, and Processes for Their Preparation
Patent:
6,538,151 →
Application:
09/181,671 →
G-Rich Oligo Aptamers and Methods of Modulating an Immune Response
Patent:
6,994,959 →
Application:
09/331,204 →
Use of Retigabine for the Treatment of Neuropathic Pain
Patent:
6,117,900 →
Application:
09/406,135 →
Cytokine Related Treatments of Disease
Patent:
6,423,695 →
Application:
09/467,443 →
Heterocyclic Compounds and Uses Thereof
2-Beta-Modified-6-Substituted Adenosine Analogs and Their Use as Antiviral Agents
Combinations of Retigabine and Sodium Channel Inhibitors or Sodium Channel-Influencing Active Compounds for Treating Pains
Quinoxaline Derivatives Having Antiviral Activity
Substituted Arylamino -1,2,3,4-Tetrahydro Naphthalenes and -2,3-Dihydro-1H-Indenes as Potassium Channel Modulators
N-[2-Amino-4-(Phenylmethoxy)Phenyl] Amides and Related Compounds as Potassium Channel Modulators
1,4 Diamino Bicyclic Retigabine Analogues as Potassium Channel Modulators
Derivatives of 4-(N-Azacycloalkyl) Anilides as Potassium Channel Modulators
3-Hydroxyisothiazole-4-Carboxamidine Derivatives as CHK2 Inhibitors
Naphthyridine Derivatives as Potassium Channel Modulators
Derivatives of 5-Amino-4,6-Disubstituted Indole and 5-Amino-4,6-Disubstituted Indoline as Potassium Channel Modulators
Benzyloxy Anilide Derivatives Useful as Potassium Channel Modulators
Derivatives of 5-Amino-4,6-Disubstituted Indole and 5-Amino-4,6-Disubstituted Indoline as Potassium Channel Modulators
Substituted Arylamino-1,2,3,4-Tetrahydro Naphthalenes and -2,3-Dihydro-1H-Indenes as Potassium Channel Modulators
Benzyloxy Anilide Derivatives Useful as Potassium Channel Modulators
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 3, 2009
From: VERNIER, JEAN-MICHEL; CHEN, HUANMING; SONG, JIANLIN
To: VALEANT PHARMACEUTICALS INTERNATIONAL
Reel/Frame 022199/0794 →
Assignment of Assignor's Interest
Mar 5, 2009
From: VERNIER, JEAN-MICHEL; DE LA ROSA, MARTHA
To: VALEANT PHARMACEUTICALS INTERNATIONAL
Reel/Frame 022353/0513 →
Assignment of Assignor's Interest
Sep 14, 2009
From: WU, JIM ZHEN; VERNIER, JEAN-MICHEL; CHEN, HUANMING; SONG, JIANLAN
To: VALEANT PHARMACEUTICALS INTERNATIONAL
Reel/Frame 023228/0259 →
Security Agreement
Oct 4, 2010
From: ATON PHARMA, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA; VALEANT PHARMACEUTICALS INTERNATIONAL; CORIA LABORATORIES, LTD.
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 025084/0169 →
Assignment of Assignor's Interest
Feb 16, 2011
From: WU, JIM ZHEN; CHEN, HUANMING
To: VALEANT PHARMACEUTICALS INTERNATIONAL
Reel/Frame 025821/0733 →
Patent Security Release Agreement
Mar 14, 2011
From: GOLDMAN SACHS LENDING PARTNERS LLC
To: VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS NORTH AMERICA; CORIA LABORATORIES, LTD.; DOW PHARMACEUTICAL SCIENCES, INC.
Reel/Frame 025950/0048 →
Corrective Assignment to Correct the Assignee Name Previously Recorded on Reel 020485 Frame 0047. Assignor(S) Hereby Confirms the Conveying Parties Have Corrected the Assignee's Name.
Jul 12, 2011
From: CHEN, HUANMING; VERNIER, JEAN-MICHEL
To: VALEANT PHARMACEUTICALS INTERNATIONAL
Reel/Frame 026578/0679 →
Security Agreement
Jul 18, 2011
From: VALEANT PHARMACEUTICALS INTERNATIONAL, A DELAWARE CORPORATION; ATON PHARMA, INC., A DELAWARE CORPORATION; CORIA LABORATORIES, LTD., A DELAWARE CORPORATION; DOW PHARMACEUTICAL SCIENCES, INC., A DELAWARE CORPORATION
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 026606/0061 →
Corrective Assignment to Correct the Assignee Name Previously Recorded on Reel 020760 Frame 0563. Assignor(S) Hereby Confirms the Conveying Parties Have Corrected the Assignee's Name.
Jul 28, 2011
From: VERNIER, JEAN-MICHEL; SONG, JIANLAN; CHEN, HUANMING; HONG, ZHI
To: VALEANT PHARMACEUTICALS INTERNATIONAL
Reel/Frame 026669/0063 →
Corrective Assignment to Correct the Assignee Name Previously Recorded on Reel 021089 Frame 0934. Assignor(S) Hereby Confirms the Conveying Parties Have Corrected the Assignee's Name.
Jul 28, 2011
From: CHEN, HUANMING; SONG, JIANLAN; VERNIER, JEAN-MICHEL; WU, JIM ZHEN
To: VALEANT PHARMACEUTICALS INTERNATIONAL
Reel/Frame 026669/0016 →
Security Agreement
Nov 23, 2011
From: KADMON CORPORATION, LLC
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 027278/0787 →
Security Interest
Jul 30, 2012
From: VALEANT PHARMACEUTICALS INTERNATIONAL
To: GOLDMAN SACHS LENDING PARTNERS LLC
Reel/Frame 028680/0874 →
Security Agreement
Jun 25, 2013
From: KADMON CORPORATION LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 030679/0116 →
Security Agreement
Jun 25, 2013
From: KADMON CORPORATION LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 030679/0212 →
Notice of Succession of Agency
Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
Security Interest
Jul 18, 2016
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSH & LOMB PHARMA HOLDINGS CORP.; DENDREON PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC
Reel/Frame 039380/0385 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest
Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Intellectual Property Security Agreement
Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
Security Interest
Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
Security Agreement
Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
Security Agreement (First Lien)
Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
Security Agreement (Second Lien)
Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
Security Interest
Feb 13, 2023
From: BAUSCH HEALTH COMPANIES INC.; VALEANT CANADA LP; VALEANT CANADA GP LIMITED; V-BAC HOLDING CORP.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 062670/0260 →